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Post-translational modifications of individual lysine
residues of core histones can exert unique functional
consequences. For example, methylation of histone H3
at lysine 79 (H3-meK79) has been implicated recently in
gene silencing in Saccharomyces cerevisiae. However,
the distribution and function of H3-meK79 in mamma-
lian chromatin are not known. We found that H3-meK79
has a variable distribution within the murine -globin
locus in adult erythroid cells, being preferentially en-
riched at the active major gene. By contrast, acetylated
H3 and H4 and H3 methylated at lysine 4 were enriched
both at major and at the upstream locus control region.
H3-meK79 was also enriched at the active cad gene,
whereas the transcriptionally inactive loci necdin and
MyoD1 contained very little H3-meK79. As the pattern of
H3-meK79 at the -globin locus differed between adult
and embryonic erythroid cells, establishment and/or
maintenance of H3-meK79 was developmentally dy-
namic. Genetic complementation analysis in null cells
lacking the erythroid and megakaryocyte-specific tran-
scription factor p45/NF-E2 showed that p45/NF-E2 pref-
erentially establishes H3-meK79 at the major pro-
moter. These results support a model in which H3-
meK79 is strongly enriched in mammalian chromatin at
active genes but not uniformly throughout active chro-
matin domains. As H3-meK79 is highly regulated at the
-globin locus, we propose that the murine ortholog of
Disruptor of Telomeric Silencing-1-like (mDOT1L) meth-
yltransferase, which synthesizes H3-meK79, regulates
-globin transcription.
Post-translational modification of core histones in chromatin
represents a common epigenetic mechanism that controls di-
verse nuclear processes. An almost endless number of histone
modifications has been documented, and it has been hypothe-
sized that a histone code exists in which unique combinations
of histone modifications confer distinct functional conse-
quences (1). Acetylation of core histones enhances factor access
to the chromatin template by increasing accessibility of nucleo-
somal DNA (2, 3). Increased accessibility does not appear to be
accompanied by a major change in nucleosome structure in
vitro (4, 5). However, a 3-fold increase in acetylation strongly
inhibits folding of chromatin fibers into higher order structures
(6). Furthermore, the acetylated amino-terminal tails of core
histones are recognized by bromodomains (7, 8), which are
often present in coactivators that mediate transcriptional acti-
vation. Although the structure of acetylated chromatin and the
functional implications of acetylation have been studied for
many years (9), considerably less is known about other histone
modifications such as methylation.
The concept of a histone code is illustrated by methylation of
histone H3 at amino acids 4 and 9. Histone H3 methylated at
lysine 9 (H3-meK9),1 but not at lysine 4 (H3-meK4), is selec-
tively recognized by heterochromatin protein 1 (HP1) (10–14).
HP1 serves an important role in the assembly of repressive
chromatin structures (15), thus linking a site-specific histone
modification to heterochromatin formation. By contrast, H3-
meK4 is preferentially enriched in transcriptionally active
chromatin (16–18), including transcriptional regulatory ele-
ments such as the murine -globin locus control region (LCR)
(Fig. 1) (18, 19). However, H3-meK4 is not uniformly present
throughout the active -globin locus in adult murine erythroid
cells (18). The central portion of the locus, which contains the
Ey and H1 embryonic -globin genes and is characterized by
broad, low level acetylation (19–21), also has low level H3-
meK4. H3 dimethylated at Lys-4 is enriched within coding
regions of transcribed genes in yeast, and this modification is
established by the methyltransferase Set1 (22). A more recent
analysis in yeast revealed that H3 dimethylated at Lys-4 was
enriched at active and inactive genes, whereas H3 trimethyl-
ated at Lys-4 marked only active genes (23). The functional
consequences of H3-meK4 include inhibiting interaction of the
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nucleosome remodeling and deacetylase repressor complex
with the amino terminus of H3; H3-meK9 does not prevent
nucleosome remodeling and deacetylase repressor complex
binding (24, 25).
In addition to acetylation and methylation of Lys-4 and Lys-9
within the amino terminus of histone H3, H3 is modified in the
central globular domain by methylation at Lys-79 (26–28).
Lys-79 methylation is catalyzed by the histone methyltrans-
ferase disruptor of telomeric silencing 1 (DOT1) in yeast (26–
28) and DOT1-like protein (DOT1L) in humans (29). Methyla-
tion of H3 at Lys-79 requires Rad6-mediated ubiquitination of
Lys-123 of H2B (H2B-K123) (30, 31), analogous to the coupling
of H2B ubiquitination and methylation of H3 at Lys-4 (32).
DOT1 was identified by a genetic screen in yeast to isolate
genes that disrupt telomeric silencing (33). DOT1 was also
identified as a regulator of the pachytene checkpoint, which
ensures proper chromosome segregation during the meiotic cell
cycle (34). Mutation of Lys-79 and mutations that abrogate
DOT1 catalytic activity impair telomeric silencing (26, 27),
indicating that DOT1 mediates telomeric silencing via methy-
lation of Lys-79. Taken together with results that H3-meK79 is
abundant in bulk yeast histones and is deficient from telo-
meres, it has been proposed that H3-meK79 excludes silent
information regulator (SIR) complexes (27). SIR complexes as-
semble at telomeres and mediate heterochromatin formation
(35). The model assumes that H3-meK79 excludes SIR proteins
from the bulk of genomic DNA, thus yielding sufficient
amounts of SIR proteins to assemble repressive complexes at
heterochromatic sites.
The studies described above have led to a compelling model
to explain the functional consequences of H3-meK79 in yeast.
However, given the considerably larger size of mammalian
genomes versus the yeast genome, it would be striking if all
active chromatin regions require H3-meK79 to prevent SIR-
mediated heterochromatization. The distribution of H3-meK79
in mammalian chromatin has not been determined. Thus, we
developed a quantitative chromatin immunoprecipitation
(ChIP) assay to measure H3-meK79 levels at a mammalian
chromatin domain, the erythroid-specific murine -globin lo-
cus, and at other functionally distinct sites of mammalian
chromatin. Although the distribution of H3-meK79 at these
sites is consistent with the model in which H3-meK79 is en-
riched at active promoters, surprisingly, H3-meK79 levels were
highly variable throughout the active -globin domain in adult
erythroid cells. As H3-meK79 levels were dynamically regu-
lated by the hematopoietic activator p45/NF-E2 and differed
between adult and embryonic erythroid cells, H3-meK79 is
likely to be an important determinant of -globin gene
expression.
EXPERIMENTAL PROCEDURES
Cell Culture—MEL (36) and p45/NF-E2-null CB3 (37) cells were
maintained in Dulbecco’s modified Eagle’s medium (Biofluids) contain-
ing 1% antibiotic/antimycotic (Invitrogen) and 5% calf serum, 5% fetal
calf serum (MEL), or 10% fetal calf serum (CB3). Stably transfected
clones of CB3 cells expressing p45/NF-E2 (WT) (38) were selected and
maintained in 1 mg/ml G418 sulfate (Calbiochem). Cells were grown in
a humidified incubator at 37 °C in the presence of 5% carbon dioxide.
Chromatin Immunoprecipitation Assay—ChIP was performed as de-
scribed (18, 19, 39). Erythroid maturation of MEL cells was induced by
treatment of 0.5  105 cells/ml with 1.5% Me2SO (Sigma) for 4 days.
Aliquots of immunoprecipitated chromatin (1.5 l) were analyzed by
real time PCR as described (18, 19, 39). Primers were designed by
Primer Express R 1.0 software (PE Applied Biosystems) to amplify
50–150-bp products. Samples from at least two independent immuno-
precipitations were analyzed.
ChIP primer pairs to amplify -globin locus sequences were based on
Hbbd haplotype sequences (GenBankTM accession numbers Z13985,
X14061, AF128269, and AF133300). Real time PCR primers (5-3) are
as follows: HS2, AGTCAATTCTCTACTCCCCACCCT and ACTGCTG-
TGCTCAAGCCTGAT; IVR3, TGTGCTAGCCTCAAGCTCACA and
TCCCAGCACTCAGAAGAAGGA; major, CAGGGAGAAATATGCTT-
GTCATCA and GTGAGCAGATTGGCCCTTACC; major I2, CTTCTC-
TCTCTCCTCTCTCTTTCTCTAATC and AATGAACTGAGGGAAAGG-
AAAGG; necdin 5, TTCAGTAGCTGATGCCCAGGT and GGGAGGAT-
ACCAGAGATGGGA; necdin promoter, GGTCCTGCTCTGATCCGAAG
and GGGTCGCTCAGGTCCTTACTT; necdin 3, TTCAACTGGCACAG-
GAAGCA, AACAGTCCAGTTCAAATCAGTCCAT; MyoD1 5, CCAGA-
TCTCAGTGCTGCAGG and CCGCTTGCATAGCATAACCAG; MyoD1
promoter, GGGTAGAGGACAGCCGGTGT and GTACAATGACAAAG-
GTTCTGTGGGT; MyoD1 3, TACCCAAGGTGGAGATCCTGC and
GCAGACCTTCGATGTAGCGGAT; cad, TTCTAACTTGACCGGCTGG-
TTT and GGACCATAGGATGGTTCCACAG; and cad exon2, GCCCTC-
ACTGACCCTTCCTAC and TTGCCGATGAGAGGATACGTT.
Antibodies—Anti-acetylated histone H3 (06-599) and anti-H3-meK4
(07-030) antibodies were obtained from Upstate Biotechnology, Inc.
Anti-H3 dimethyl Lys-79 was described previously (26). Preimmune
rabbit serum served as a control for the specific antibodies.
RT-PCR Analysis—Total RNA was prepared from the same CB3 and
WT cells used for ChIP with Trizol (Invitrogen). cDNA was synthesized
by annealing RNA (1 g) with 250 ng of a 5:1 mixture of random and
oligo(dT) primers by heating at 68 °C for 10 min. After denaturation,
samples were incubated with reverse transcriptase (Superscript II,
Invitrogen) combined with 10 mM dithiothreitol, RNasin (Promega),
and 0.5 mM dNTPs for 1 h at 42 °C. The reaction mixture was diluted to
a final volume of 150 l and heat-inactivated at 95–99 °C for 5 min.
Quantitative real time RT-PCRs (25 l) contained 2.5 l of cDNA, 12.5
l of SYBR Green (Applied Biosystems), and the appropriate primers.
Product accumulation was monitored by SYBR Green fluorescence.
Relative expression levels were determined from a standard curve of
serial dilutions of MEL cDNA samples. Forward and reverse primers
for real time RT-PCR (5-3) are as follows: -globin, CAGCCTCAGT-
GAGCTCCACTG and GATCATATTGCCCAGGAGCC; and glyceralde-
hyde-3-phosphate dehydrogenase, GAAGGTACGGAGTCAACGGATTT
and GAATTTGACCATGGGTGGAAT.
Protein Analysis—Lysates were prepared by boiling cells for 5 min in
SDS sample buffer (50 mM Tris (pH 6.8), 100 mM dithiothreitol, 2% SDS,
0.1% bromphenol blue, 10% glycerol). Extracts from 1  105 cells were
resolved on SDS-polyacrylamide gels, transferred to Immobilon P mem-
branes (Millipore), and analyzed by Western blotting as described (18).
Blots were incubated with anti-p45/NF-E2 antibody (40), followed by
protein A-peroxidase (Sigma) and detected via chemiluminescence with
an ECL-plus kit (Amersham Biosciences).
Differentiation of Murine Embryonic Stem Cells into Primitive Eryth-
roid Colonies—Murine ES cells were differentiated into EryP as de-
scribed (41, 42). Briefly, day 4 embryoid bodies were collected, dissoci-
ated with trypsin, and replated at 1  105/ml in methylcellulose (Sigma)
containing 10% plasma-derived serum (Antech, Tyler, TX), 5% protein-
free hybridoma medium (PFHM2, Invitrogen), L-glutamine (2 mM),
transferrin (300 g/ml; Roche Molecular Biochemicals), and monothio-
glycerol (4.5  104 M), together with 2 units/ml erythropoietin (Amgen,
Thousand Oaks, CA). Primitive erythroid colonies were collected 4 days
later via digestion with cellulase (1 unit/ml) for 20 min at 37 °C. Cells
were resuspended in culture media, cross-linked with 0.4% formalde-
hyde for 10 min at room temperature, and analyzed by ChIP as de-
scribed above with the cell lines.
RESULTS AND DISCUSSION
Quantitative Analysis of H3-meK79 Levels in Mammalian
Chromatin—A quantitative ChIP assay was developed to
measure H3-meK79 levels in mammalian chromatin (Fig. 2).
We initially analyzed the distribution of H3-meK79 within the
erythroid-specific -globin locus (Fig. 1) in Me2SO-induced
MEL cells, which express high levels of the adult -globin gene
major. The cross-linked chromatin fragments used for ChIP
had an average size of 400–500 bp (Fig. 2A), and assays were
FIG. 1. Organization of the murine Hbbd -globin locus. The
murine -globin locus contains embryonic (Ey and H1) and adult
(major and minor) -globin genes. -Globin genes are shown as boxes
and HSs as spheres. HS, DNase I-hypersensitive site. The lower bars
indicate H3- and H4-hyperacetylated zones.
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conducted under linear conditions (Fig. 2B). Representative
amplification curves for the detection of H3-meK79 at HS2 of
the LCR and at the major promoter are shown in Fig. 2C.
Thermal dissociation of the PCR products revealed a homoge-
nous dissociation curve (Fig. 2D), indicative of a single major
PCR product for each primer set.
Analysis of H3-meK79 at functionally distinct sites of the
-globin locus (Fig. 3A) revealed strong enrichments at the
active major promoter and within the major gene at intron 2
(Fig. 3B). By contrast, H3-meK79 levels were low at HS2, at the
inactive H1 promoter, and at the representative intergenic
site IVR3. IVR3 does not contain known functionally relevant
sequences. Acetylated H3 was high at HS2, at the major
promoter, and at major intron 2. The fact that H3-meK79 was
considerably lower at HS2 versus the major promoter was
surprising, because we showed previously (18–20) that other
histone modifications, notably acetylated H3, acetylated H4,
and H3-meK4, are strongly enriched at both the HS2 and the
major promoter. Based on the fact that 90% of yeast histone
H3 is methylated at Lys-79, and based on the SIR localization
model (27), we reasoned that H3-meK79 might be uniformly
enriched throughout the active -globin domain. Rather, H3-
meK79 had a highly variable distribution, paralleling the dis-
tribution of acetylated H3, with the exception that H3-meK79
was low at HS2 (Fig. 3B).
To gain a broader perspective of how H3-meK79 is distrib-
uted in mammalian chromatin, we measured H3-meK79 at
other active and inactive genes (Fig. 4). H3-meK79 levels were
high at both the promoter and exon 2 of the broadly expressed
cad gene. By contrast, upstream sequences, promoters, and
exonic sequences from the inactive neuronal-specific necdin
gene and the muscle-specific MyoD1 gene had very low levels of
H3-meK79. Thus, taken together with the -globin results of
Fig. 3, H3-meK79 levels are highest at active genes.
FIG. 3. Acetylated histone H3 and H3-meK79 have distinct patterns at the -globin locus of Me2SO-induced MEL cells. A,
organization of the murine -globin locus. B, cross-linked chromatin was isolated from Me2SO-induced MEL cells. The relative levels of H3-meK79
and H3 acetylation were measured by quantitative ChIP analysis at various sites of the endogenous murine -globin locus (mean  S.E., at least
three independent experiments). Note that the first four graphs have a common y axis with the units indicated on the left, and the graph depicting
maj I2 data has a distinct y axis. Pro, promoter; I2, intron 2; PI, preimmune; acH3, acetylated H3.
FIG. 2. Quantitative ChIP analysis
of H3-meK79 at the murine -globin
locus. A, agarose gel analysis of soni-
cated, deproteinized chromatin used in
the ChIP assay. Chromatin fragments
smaller than 1 kb, averaging 400–500
bp, were visualized by ethidium bromide
staining. B, standard curves of SYBR
Green fluorescence signals obtained from
dilutions of input DNA from induced MEL
cells using HS2 and major promoter spe-
cific primer pairs. C, representative am-
plification plot of H3-meK79 at HS2 and
major promoter in induced MEL cells;
PI, preimmune. D, dissociation plot ob-
tained from amplicon shown in C. The
single peak indicates the generation of
single amplicon for each primer pair.
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Dynamic Regulation of H3-meK79 at the Endogenous Murine
-Globin Locus—We showed previously (20) that the central
region of the murine -globin locus, characterized by low level
histone acetylation in adult erythroid cells, is highly acetylated
in embryonic erythroid cells of a 10.5-day post-conception mu-
rine yolk sac. This result indicated that the acetylation pattern
of the -globin locus is developmentally dynamic. Accordingly,
we hypothesized that establishment of broad low level acetyla-
tion at the central subdomain of the -globin locus, which
contains the embryonic Ey and H1 genes, was required for
silencing of the embryonic -globin genes. Based on the low
level H3-meK79 at the H1 promoter and at IVR3, both resid-
ing within the central subdomain, we asked whether establish-
ment and/or maintenance of H3-meK79 is developmentally
dynamic. Rather than using yolk sac as in our previous anal-
ysis, we used primitive erythroid cells derived from murine ES
cells via in vitro differentiation (Fig. 5A). This in vitro differ-
entiation system recapitulates regulatory events occurring dur-
ing normal erythropoiesis (41–44). As large numbers of embry-
onic erythroid cell colonies, EryP, can be readily differentiated
from ES cells, and it is difficult to obtain large numbers of
primary embryonic erythroid cells from murine yolk sac, the
ES cell system has major advantages for analyzing the chro-
matin structure of the -globin locus during embryonic eryth-
ropoiesis. No ChIP analyses have been described using specific
cell types differentiated from ES cells.
Similar to the -globin locus of induced MEL cells (Fig. 3),
H3-meK79 was enriched at the major promoter in EryP cells
(Fig. 5B). Despite the fact that these cells are embryonic, EryP
express low levels of major (data not shown). By contrast to
the results with induced MEL cells (Fig. 3), H3-meK79 was
high at IVR3 and the active H1 promoter. Only low levels of
H3-meK79 were apparent at the inactive necdin promoter,
whereas H3-meK79 was enriched at the active cad promoter,
comparable to induced MEL cells. Thus, H3-meK79 was devel-
opmentally dynamic at IVR3 and the H1 promoter, being high
in EryP (embryonic erythroid cells) and low in induced MEL
cells (adult erythroid cells). The developmentally specific H3-
meK79 patterns suggest an important regulatory role for H3-
meK79 in controlling -globin expression during erythropoie-
FIG. 4. H3-meK79 is preferentially enriched at transcription-
ally active genes. Cross-linked chromatin was isolated from Me2SO-
induced MEL cells. The relative levels of H3-meK79 and H3 acetylation
were measured by quantitative ChIP analysis at cad promoter, cad
exon 2, upstream from necdin (necdin 5), necdin promoter, necdin exon
1, upstream of MyoD1 (MyoD1 5), MyoD1 promoter, and MyoD1 exon 1.
Mean  S.E. of at least three independent experiments. Pro, promoter;
E1, exon 1; E2, exon 2; 5, 5 upstream; PI, preimmune; acH3, acety-
lated H3.
FIG. 5. In contrast to Me2SO-induced MEL cells, H3-meK79 is
broadly distributed throughout the -globin domain in primi-
tive erythroid cells derived from murine embryonic stem cells.
A, EryP cells were generated via in vitro differentiation of murine ES
cells. B, cross-linked chromatin was isolated from EryP, and the rela-
tive level of H3-meK79 was measured by quantitative ChIP analysis
(mean  S.E. of two independent experiments). Pro, promoter;
PI, preimmune.
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sis. H3-meK79 levels at HS2 were 2.8-fold greater in EryP
versus induced MEL cells. However, H3-meK79 at HS2 in EryP
was much lower than at the active H1 promoter, analogous to
the result in induced MEL cells, in which H3-meK79 was much
lower at HS2 versus the active major promoter.
We have shown that acetylated H3, H3-meK4, and to a lesser
extent, acetylated H4 are induced by p45/NF-E2 at the major
promoter in CB3 erythroleukemia cells, which lack p45/NF-E2
(18, 45). Given the developmental modulation of H3-meK79, we
tested whether establishment of H3-meK79 at the major pro-
moter is p45/NF-E2-dependent (Fig. 6). H3-meK79 levels were
compared in CB3 cells lacking or stably expressing physiolog-
ical levels of the two p45/NF-E2 isoforms (Fig. 6A). Expression
of p45/NF-E2 in CB3 cells strongly activated -globin tran-
scription as expected (Fig. 6B). ChIP analysis revealed that
H3-meK79 was only high at the major promoter when p45/
NF-E2 was expressed (Fig. 6C). Similarly, establishment of
H3-meK4 and acetylated H3 at the promoter was p45/NF-E2-
dependent, consistent with our previous results (18, 45).
Because H3-meK79 was present at HS2 in induced MEL
cells, albeit at low levels (Fig. 3), we also tested whether p45/
NF-E2 is important for establishing H3-meK79 at HS2. How-
ever, H3-meK79 at HS2 was insensitive to p45/NF-E2. Simi-
larly, p45/NF-E2 only slightly affected the levels of H3-meK4
and acetylated H3 at HS2, consistent with our previous results
(18, 45). Taken together with the results of Fig. 5, H3-meK79
levels are highly regulated at the -globin locus via develop-
mental signals and by the hematopoietic-specific activator
p45/NF-E2.
Mechanistic Insights Arising from the H3-meK79 Pattern in
Mammalian Chromatin—The distribution of H3-meK79 in
mammalian chromatin had not been measured previously. Our
results on the distribution of H3-meK79 at functionally distinct
sites of mammalian chromatin are summarized in Fig. 7. Re-
sults described herein support a model in which H3-meK79 is
highly enriched in mammalian chromatin at active genes. Con-
versely, inactive genes are characterized by low level or no
detectable H3-meK79. Because our results demonstrate that
H3-meK79 is dynamically regulated, resembling the other
functionally important modifications H3-meK4 and acetylated
H3, we propose that H3-meK79 and, importantly, enzymes that
establish H3-meK79, regulate -globin expression. As multiple
histone modifications of the -globin locus are insensitive to
transcriptional inhibition by the elongation inhibitor 5,6-di-
chloro-1--D-ribofuranosyl-benzimidazole (data not shown), it
is highly unlikely that dynamic changes in these modifica-
tions result from altered transcriptional activity. Rather,
changes in histone modifications at the -globin locus are
likely to regulate transcription.
It is instructive to relate our results to the current model for
the function of H3-meK79 derived from studies in yeast (27).
Genetic and biochemical analysis provided evidence that DOT1
methylates H3 at Lys-79 and is required for telomeric silencing
(26–28). As summarized in the Introduction, it was proposed
that H3-meK79 excludes SIR silencing complexes, which are
critical for heterochromatin formation (27). Our results show-
ing that inactive genes have low or undetectable levels of H3-
meK79 are consistent with this model. However, the variable
FIG. 6. p45/NF-E2-dependent establishment of H3-meK79 at the major promoter but not at HS2. A, Western blot analysis of
p45/NF-E2 expression in total cell lysates from CB3, CB3-WT21, and Me2SO-induced MEL cells. The arrows depict two p45/NF-E2 isoforms, which
result from usage of distinct translation start sites. No functional differences have been ascribed to the two isoforms. B, real time RT-PCR analysis
of -globin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) RNA expression in CB3 and CB3-WT21 cells. C, relative levels of H3-meK79,
H3-meK4, and H3 acetylation were measured by quantitative ChIP analysis at HS2, IVR3, H1 promoter, major promoter, and MyoD1 promoter
in CB3 and CB3-WT21 (mean  S.E. of three independent experiments, except for H3-meK4 levels at HS2 in CB3-WT21, which represent duplicate
values). Pro, promoter; PI, preimmune; acH3, acetylated H3.
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distribution of H3-meK79 throughout the mammalian -globin
locus in adult erythroid cells, being almost entirely absent from
sites within the central subdomain and at HS2, was not pre-
dictable from the yeast model.
Why would the central subdomain and HS2 have such low
levels of H3-meK79 in induced MEL cells? The central subdo-
main also has low levels of acetylated histones H3 and H4 (19,
20) and H3-meK4 (18), is inaccessible to restriction endonucle-
ases, and contains sites highly modified by CpG dinucleotide
methylation (19). The histone acetylation pattern of MEL cells
is physiologically relevant, because it is similar to that of nor-
mal adult erythroid cells of the 14.5-day post-conception mu-
rine fetal liver (20). It is unknown whether SIR proteins are
components of the repressive chromatin structure of the cen-
tral subdomain in erythroid cells. The low level H3-meK79 at
the central subdomain might allow SIR proteins to localize to
the central subdomain, thereby facilitating assembly of repres-
sive complexes to establish and maintain the silent state of the
embryonic -globin genes. Alternatively, other factors might
preclude the need to utilize H3-meK79 to exclude SIR proteins
from the central subdomain.
Based on the recent cloning of human DOT1L, which cata-
lyzes methylation of histone H3 at Lys-79 (29), and the dy-
namic regulation of H3-meK79 at the -globin locus, we pro-
pose that mDOT1L is an important regulator of -globin gene
transcription. Whereas acetylated H3 and H4 and H3-meK4,
which are hallmarks of active chromatin, are highly enriched
at the LCR and the active promoters (18, 20), H3-meK79 is
uniquely high at active genes in induced MEL cells (Fig. 3). The
variable distribution of H3-meK79 within the -globin locus in
MEL cells is consistent with an important regulatory function
of H3-meK79 locally at the active adult -globin genes. By
contrast, H3-meK79 had a broader distribution throughout the
locus in EryP, and notably the intergenic site IVR3 of the
central subdomain had high levels of H3-meK79. The EryP
results indicate that H3-meK79 does not reside exclusively at
active promoters and genes.
In summary, we have described the first analysis of the
distribution of H3-meK79 in mammalian chromatin. This anal-
ysis in adult and embryonic erythroid cells yielded patterns
that were not predictable from prior studies in yeast. H3-
meK79 was considerably more enriched at the major pro-
moter versus HS2, and H3-meK79 represents the only histone
modification detected to date that is preferentially enriched at
major. Based on these findings, it will be important to deter-
mine how mDOT1L expression and activity are regulated dur-
ing erythropoiesis and whether hematopoietic specific activa-
tors differentially recruit mDOT1L to the -globin locus in
embryonic and adult erythroid cells.
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